
By Collin West
At my prior fund, we invested in the Series B of Sidecar Health with Alex Lazarow at Cathay Innovation. Now, only six months later, they announced a $125 million raise at a $1 billion valuation. Our original investment thesis can be found here: How to Save $1 Trillion in Healthcare.
Since the fundraise, the Sidecar Health team has been busy turning their vision into a reality. We sat down with Patrick Quigley, Sidecar Health CEO, to get an update on the recently-minted unicorn.
A Change in Philosophy
Their team is motivated by a singular mission: to make healthcare affordable and accessible for everyone in the United States. This one idea drives all their major decisions.
“We are creating a new way to purchase healthcare. We give people the information they need to make purchasing decisions, like they have access to in every other market,” stated Patrick. “This is not some niche product. This is an entirely new philosophical approach to the U.S. healthcare system.”
Another Sidecar Health investor Alex Lazarow, Partner at Cathay Innovation, agrees: “Sidecar Health is not about incremental improvement to the health insurance market. It is about fundamentally rethinking how it is structured, shifting the underlying incentives and how healthcare is paid for. They are a strong example of an emerging cadre of startups that combine business model and technological shifts to drive greater access and better delivery of high impact products and services."
When we first spoke to Sidecar Health, they had internal benchmarks that they wanted to hit. They were eager to get the results and see if consumers would save money compared to the way that care and payments are handled today.
“After looking at the claims data from thousands of users, we see that price transparency reduces the cost of care. In many cases, the savings exceed 30%,” shared Patrick. This savings allows Sidecar Health to offer better coverage for a lower price, which is great for patients. This also makes it difficult for other insurers to compete on price.
These findings are particularly exciting because they confirm the research from Vanderbilt professor and economist Larry Van Horn, who is an advisor to the company.
How are Healthcare Providers Responding?
The Sidecar product offering is clearly working for consumers – but what about healthcare providers? Since introducing their upfront cash model, most healthcare providers have been enthusiastic supporters.
“Providers want to get paid quickly and the providers themselves set the cash price, not Sidecar Health. This is an important distinction,” said Patrick. “Providers can set prices wherever they want, and decide how they want to balance business levels and profitability. Their patients – now consumers – can shop with total confidence knowing exactly what services and procedures will cost.”
Unlike reference-based pricing models, Sidecar Health pays immediately when members use their payment card. Sidecar Health members can choose any provider, and are responsible for the shortfall (if any) between the benefit amount and the provider charge. In cases when the benefit amount exceeds the provider’s price, which happens frequently, Sidecar Health members keep the difference.
Their approach has been incredibly successful. In January 2021, Sidecar Health announced they recently joined the Unicorn Club due to the success of their product offerings. This capital will be used to fuel their expansion into new markets. “Our early membership has proven this model. Now we are taking the company to the next level. This round of financing is really about scaling our mission to make healthcare more affordable for everyone.”
Optimus to Optimist: The Next Generation of Primes Pt. 2
In the second part of a two-part series, Ensemble VC explores how emerging defense tech startups are reshaping the military-industrial landscape. With AI, structural reforms, and a changing geopolitical environment, new defense primes are rising to meet the challenges of modern warfare.
Optimus to Optimist: The Next Generation of Primes Pt. 1
In the first part of a two-part series on innovation in the defense industry, Ensemble VC examines the historical context behind the "military-industrial complex," and the failure of a consolidated set of prime contractors to innovate in line with adversaries despite no shortage of innovation in the larger economy.
The Future of Healthcare Tech Adoption: From Top-Down to Practitioner-First
Danny Freed and Blueprint are redefining healthcare tech adoption with practitioner-first AI tools that streamline workflows and prioritize patient care. By empowering providers instead of replacing them, they’re addressing the inefficiencies of top-down mandates to drive meaningful change in healthcare.
Clazar raises $10M to revolutionize the way software is bought and sold
Ensemble is proud to announce our most recent investment in Clazar, a company powering software businesses to sell and grow revenue through cloud marketplaces, like AWS, Azure, and GCP.